norgineventures.com Open in urlscan Pro
62.138.4.122  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * About Us
 * Investment Team
 * Portfolio
 * News
 * Contact
 * Menu Menu




 * NORGINE VENTURES IS A LEADING PROVIDER OF FINANCING FOR INNOVATIVE HEALTHCARE
   COMPANIES

 * Norgine Ventures is a leading provider of financing for innovative healthcare
   companies


INNOVATIVE HEALTHCARE FINANCING


INNOVATIVE HEALTHCARE FINANCING



Norgine Ventures was started in 2012 . Norgine Ventures provides debt and
debt-like financing to innovative, fast-growing companies in the fields of
healthcare and life sciences, in Europe and the US.

To date, Norgine Ventures has invested in a number of businesses, including
specialty pharma, diagnostic, digital health and medical device companies, at
various stages of their life cycle, both in Europe and in the US.

NORGINE VENTURES WERE UNBELIEVABLE. WE WERE A VERY YOUNG COMPANY WITH NOT MUCH
TRACK RECORD, BUT WITH A VISION. NORGINE VENTURES BELIEVED IN US AND PROVIDED
MUCH NEEDED FINANCING AT THE RIGHT TIME ON EXTREMELY GOOD FINANCIAL TERMS…
WORKING WITH THE TEAM WAS FANTASTIC… WE EXITED EXTREMELY WELL A FEW YEARS LATER
AND IF IT WAS NOT FOR NORGINE VENTURES WE WOULD NOT HAVE ACHIEVED WHAT WE DID.”

CEO of a European pharmaceutical company




NORGINE VENTURES HAS COMMITTED FUNDS IN EXCESS OF €170M TO HEALTHCARE COMPANIES
IN EUROPE AND IN THE US.





VIEW PORTFOLIO






Norgine Ventures Management Limited, Norgine House, Widewater Place, Moorhall
Road, Harefield, Uxbridge, UB9 6NS UK. Norgine Ventures Management Limited is a
limited company registered in England and Wales with company number 08723417.
NORGINE and the sail logo are trademarks of the Norgine group of companies.

Norgine Ventures Management Limited is authorised and regulated by the Financial
Conduct Authority, registration number 917803.

Investing in smaller and unlisted companies (which may be start-up or early
stage businesses) involves risks. These risks include possible loss of capital,
illiquidity and dilution. Such companies will often not pay dividends. You
should not invest in any such company (or any fund that invests in such
companies) unless you understand the risks involved, and have taken advice where
necessary. A more detailed statement of risks involved can be found here Risk
Warning.

© 2021 Norgine Ventures Management Limited.
 * Complaints Policy
 * Terms of Use
 * Cookie Policy
 * Privacy Policy
 * Terms & Conditions

Scroll to top


We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in
settings.

Close GDPR Cookie Banner
Accept Reject Settings Close GDPR Cookie Banner




Change cookie settings
Close GDPR Cookie Settings
 * Privacy Overview
 * Strictly Necessary Cookies
 * Google Analytics Cookies
 * Cookie Policy


Privacy Overview

This website uses cookies so that we can provide you with the best user
experience possible. Cookie information is stored in your browser and performs
functions such as recognising you when you return to our website and helping our
team to understand which sections of the website you find most interesting and
useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save
your preferences for cookie settings.

Enable or Disable Cookies

If you delete this cookie, we will not be able to save your preferences. This
means that each time you visit this site, you will have to enable or disable
cookies again.

Google Analytics Cookies

This website uses Google Analytics to collect anonymous information such as the
number of visitors to the site, and the most popular pages.

Enable or Disable Cookies

Please enable Strictly Necessary Cookies first so that we can save your
preferences!

Cookie Policy

More information about our Cookie Policy.

Enable All Save Changes